Live feed07:00:00·43dPRReleasevia QuantisnowZai Lab Receives U.S. FDA Fast Track Designation for Zocilurtatug Pelitecan (Zoci), a DLL3-Targeting ADC, for Treatment of Extrapulmonary Neuroendocrine Carcinomas (epNECs)ByQuantisnow·Wall Street's wire, on your screen.ZLAB· Zai Lab LimitedHealth Care
